Sarepta Therapeutics Inc
NASDAQ:SRPT

Watchlist Manager
Sarepta Therapeutics Inc Logo
Sarepta Therapeutics Inc
NASDAQ:SRPT
Watchlist
Price: 21.925 USD -1.77%
Market Cap: 2.3B USD

Intrinsic Value

The intrinsic value of one SRPT stock under the Base Case scenario is hidden USD. Compared to the current market price of 21.925 USD, Sarepta Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

SRPT Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Sarepta Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

SRPT looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if SRPT is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about SRPT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SRPT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sarepta Therapeutics Inc.

Explain Valuation
Compare SRPT to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Concerns remain over the company’s heavy reliance on its Duchenne muscular dystrophy (DMD) portfolio; any setback in its lead gene therapy program or regulatory pushback on existing therapies could have a disproportionately negative impact on overall revenue prospects.

Bull Theses

Sarepta’s leadership in precision genetic medicine for DMD, underpinned by multiple RNA-targeted therapies already on the market and an advancing gene therapy program, positions it at the forefront of treatment innovation for a high-need patient population.

Show More Less
How do you feel about SRPT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sarepta Therapeutics Inc

Current Assets 2.7B
Cash & Short-Term Investments 851m
Receivables 541.6m
Other Current Assets 1.3B
Non-Current Assets 771.1m
Long-Term Investments 9.2m
PP&E 498.1m
Intangibles 29.7m
Other Non-Current Assets 234.1m
Current Liabilities 921.4m
Accounts Payable 94m
Accrued Liabilities 157.7m
Other Current Liabilities 669.7m
Non-Current Liabilities 1.3B
Long-Term Debt 1B
Other Non-Current Liabilities 216.7m
Efficiency

Free Cash Flow Analysis
Sarepta Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sarepta Therapeutics Inc

Revenue
2.4B USD
Cost of Revenue
-573.2m USD
Gross Profit
1.8B USD
Operating Expenses
-1.9B USD
Operating Income
-86m USD
Other Expenses
-185.5m USD
Net Income
-271.5m USD
Fundamental Scores

SRPT Profitability Score
Profitability Due Diligence

Sarepta Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
hidden
Profitability
Score

Sarepta Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

SRPT Solvency Score
Solvency Due Diligence

Sarepta Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Positive Net Debt
hidden
Solvency
Score

Sarepta Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SRPT Price Targets Summary
Sarepta Therapeutics Inc

Wall Street analysts forecast SRPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SRPT is 30.15 USD with a low forecast of 5.05 USD and a high forecast of 194.25 USD.

Lowest
Price Target
5.05 USD
77% Downside
Average
Price Target
30.15 USD
38% Upside
Highest
Price Target
194.25 USD
786% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Sarepta Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SRPT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SRPT Insider Trading
Buy and sell transactions by insiders

SRPT News

Other Videos
What is the Intrinsic Value of one SRPT stock?

The intrinsic value of one SRPT stock under the Base Case scenario is hidden USD.

Is SRPT stock undervalued or overvalued?

Compared to the current market price of 21.925 USD, Sarepta Therapeutics Inc is hidden .

Back to Top